| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $0.17 | - | - |
| Q3'26 | $1.17 | $0.96 | -17.6% |
| Q3'25 | $0.18 | $0.19 | +4.9% |
| Q2'25 | $0.22 | $0.20 | -7.2% |
| Q1'25 | $0.18 | $0.18 | -1.3% |
| Q4'24 | $0.16 | $0.16 | +2.2% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $5.7B | - | - |
| Q3'26 | $6.0B | $5.9B | -1.2% |
| Q3'25 | - | $5.7B | - |
| Q2'25 | - | $5.1B | - |
| Q1'25 | - | $3.3B | - |
| Q4'24 | - | $3.2B | - |
Market Data
AMCR is currently trading at $38.97, giving Amcor plc a market cap of 18.15B and a P/E ratio of 26.8. Today's range spans $38.71–$39.41, with shares opening at $38.95 and moving up $0.14 (0.4%) from the prior close. DailyIQ's technical score sits at 27/100 (SELL) with a news sentiment reading of 78/100.
Over the past year AMCR has traded between $36.25 and $50.94 - the current price is +7.5% off the 52-week low and -23.5% from the high. 19 analysts cover the stock with a Buy consensus and a mean 12-month target of $48.21 (range $41.00–$60.00), implying upside of +23.7%.
AMCR is showing a SELL signal (27/100) with bullish sentiment (78/100). Price: $38.97 (in the lower half of its 52-week range within $36.25–$50.94). (P/E: 26.8) At 18.15B in Consumer Cyclical market cap, a bearish technical read accompanied by negative sentiment often marks the beginning of an earnings revision cycle downward - active managers trim before the revisions become consensus, compounding the selling pressure.
When a large-cap Consumer Cyclical name with 18.15B in capitalization prints a SELL signal (27/100) alongside bullish news sentiment (78/100), the risk isn't just price depreciation — it's the loss of institutional sponsorship that makes recovery harder. At $38.97 (in the lower half of its 52-week range in the $36.25–$50.94 range), the structural support levels are where that sponsorship question gets answered.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).